EPHX1 Enzyme Activity and Cancer Risk
Author Information
Author(s): Li Xiang, Hu Zheng, Qu Xinshun, Zhu Jiadong, Li Lin, Ring Brian Z., Su Li
Primary Institution: Huazhong University of Science and Technology, Wuhan, China
Hypothesis
The study investigates the relationship between EPHX1 enzyme activity, influenced by specific genetic polymorphisms, and the risk of lung and upper aerodigestive tract cancers.
Conclusion
Low EPHX1 enzyme activity may protect against tobacco-related lung and UADT cancers, while high activity may increase risk.
Supporting Evidence
- Low EPHX1 enzyme activity is associated with decreased risk of lung cancer.
- High EPHX1 activity is linked to increased risk of lung cancer.
- Modest differences in cancer risk were observed between smokers and nonsmokers.
- EPHX1 polymorphisms were evaluated in a comprehensive meta-analysis of 91 studies.
- Significant publication bias was detected in the analysis.
Takeaway
Some genes help our body break down harmful substances from smoking. This study found that certain gene changes can make it less likely to get lung cancer if they lower the activity of these genes.
Methodology
A systematic review and meta-analysis of 91 case-control studies evaluating EPHX1 polymorphisms and cancer risk.
Potential Biases
Potential publication bias was detected, particularly in the analysis of certain polymorphisms.
Limitations
Publication bias and heterogeneity among studies may affect the results.
Participant Demographics
The studies included various populations, primarily Caucasian, Asian, and African.
Statistical Information
P-Value
p=0.0002 for low EPHX1 activity and lung/UADT cancers.
Confidence Interval
95% CI for low activity allele H: 0.81–0.94; for high activity allele R: 1.03–1.22.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website